Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing
Yan Zhou, Yizhen Guo, Maoxin Ran, et al.
Cancer Letters (2023) Vol. 577, pp. 216425-216425
Closed Access | Times Cited: 21

Showing 21 citing articles:

Regulation of newly identified lysine lactylation in cancer
Xin Gao, Chaoyu Pang, Zhiyao Fan, et al.
Cancer Letters (2024) Vol. 587, pp. 216680-216680
Closed Access | Times Cited: 15
Lactoferrin conjugated radicicol nanoparticles enhanced drug delivery and cytotoxicity in prostate cancer cells
Zeinab Kooshan, Srilakshmi Srinivasan, Taskeen Iqbal Janjua, et al.
European Journal of Pharmacology (2025), pp. 177300-177300
Closed Access | Times Cited: 1
Lactoferrin-Encapsulated Dichloroacetophenone (DAP) nanoparticles enhance drug delivery and anti-tumor efficacy in prostate cancer
Sugarniya Subramaniam, Varinder Jeet, Jennifer H. Gunter, et al.
Cancer Letters (2025), pp. 217522-217522
Closed Access | Times Cited: 1
From Pathogenesis to Precision Medicine: Transformative Advances in Research and Treatment of Ameloblastoma
Zhao Zhang, Gan Xiong, Cheng Wang, et al.
Cancer Letters (2025), pp. 217448-217448
Closed Access
Interrogation of the Tumor Microenvironment by Nanoparticles
Prasanta Panja, Upender Manne, Vibhudutta Awasthy, et al.
Cancer Letters (2025), pp. 217454-217454
Closed Access
HVEM as a Tumor-Intrinsic Regulator in Non-Small Cell Lung Cancer: Suppression of Metastasis via Glycolysis Inhibition and Modulation of Macrophage Polarization
Yuanshan Yao, Bin Li, Chunji Chen, et al.
Pharmacological Research (2025), pp. 107604-107604
Open Access
Machine Learning-based Lactate-Related Genes Signature Predicts Clinical Outcomes and Unveils Novel Therapeutic Targets in Esophageal Squamous Cell Carcinoma
Chuting Yu, Yan Bian, Ye Gao, et al.
Cancer Letters (2025), pp. 217458-217458
Closed Access
Intranuclear TCA and mitochondrial overload: the nascent sprout of tumors metabolism
Weixi Yuan, Guozhong Lu, Yin Zhao, et al.
Cancer Letters (2025), pp. 217527-217527
Closed Access
Inhibition of 6-phosphogluconate dehydrogenase suppresses esophageal squamous cell carcinoma growth and enhances the anti-tumor effects of metformin via the AMPK/mTOR pathway
Wang Bei, Zixuan Wang, Zhizhen Zhou, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Combined inhibition of hexokinase 2 and pyruvate dehydrogenase surmounts SHP2 inhibitor resistance in non-small cell lung cancer with hybrid metabolic state harboring KRAS Q61H mutation
Wenying Shan, Shaolin Zhang, Yehuda G. Assaraf, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167859-167859
Closed Access
Role and targeting of the AGC kinase family in pulmonary fibrosis (Review)
Chao Mei, Tao Chen, Xiangfei Huang, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 3
Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer
Jiatong Lin, Wenhui Zhong, Zejian Lyu, et al.
Cancer Letters (2024) Vol. 589, pp. 216825-216825
Open Access | Times Cited: 3
Deciphering two decades of cellular reprogramming in cancer: A bibliometric analysis of evolving trends and research frontiers
Jinghao Liang, Yijian Lin, Yuanqing Liu, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31400-e31400
Open Access | Times Cited: 3
Lipocalin‐2 induced LDHA expression promotes vascular remodelling in pulmonary hypertension
Guoliang Wang, Shenghua Liu, Xiaohui Kong, et al.
Cell Proliferation (2024) Vol. 57, Iss. 12
Open Access | Times Cited: 3
Targeting RNA Helicase DDX3X with a Small Molecule Inhibitor for Breast Cancer Bone Metastasis Treatment
Paul T. Winnard, Farhad Vesuna, Guus M. Bol, et al.
Cancer Letters (2024), pp. 217260-217260
Closed Access | Times Cited: 2
Machine learning-based integration of CD8 T cell-related gene signatures for comprehensive prognostic assessment in lung adenocarcinoma
Jing Yong, Dongdong Wang, Huiming Yu
Translational Cancer Research (2024) Vol. 13, Iss. 7, pp. 3217-3241
Open Access | Times Cited: 1
Prediction of prognosis and immune response in lung adenocarcinoma based on mitophagy and lactate-related gene signatures
Wenjie Jiang, Fan Zhang, Zhen Tang, et al.
International Journal of Clinical Oncology (2024) Vol. 30, Iss. 2, pp. 277-297
Closed Access | Times Cited: 1
Mouse models for cancer research – current state and the perspective
Katarina Gercakova, Martina Poturnajova, Silvia Tyčiaková, et al.
Neoplasma (2024) Vol. 71, Iss. 02, pp. 99-116
Open Access
Polymeric nanoformulations aimed at cancer metabolism reprogramming with high specificity to inhibit tumor growth
Yu Xia, Ming‐Kang Zhang, Jing‐Jie Ye, et al.
Biomaterials Science (2024) Vol. 12, Iss. 19, pp. 5076-5090
Closed Access
Current hotspots and trends in cancer metabolic reprogramming: a scientometric analysis
Shanshan Yang, Miaomiao Lin, Shaodong Hao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
A practical approach for the synthesis of lactate dehydrogenase A inhibitor GNE-140
Jian Zhou, Jiaqi Liang, Qijie Gong, et al.
Tetrahedron Letters (2024) Vol. 154, pp. 155395-155395
Closed Access
Page 1

Scroll to top